As one of the most readily recognizable--and unfortunately devastating--diseases of aging, Alzheimer’s disease (AD) isa long-time focus of the research that AFAR supports.
Since 1981, AFAR has awarded over $22.3 million to 227 investigators working in Alzheimer’s disease research and related dementias at 90 institutions in 32 states, as well as Israel and Ireland.
Most recently, AFAR was delighted to assist with the presentation of the 30th annualMetLife Foundation Awards for Medical Research in Alzheimer’s Disease at the Alzheimer’s Association International Conference in Toronto. AFAR also manages the selection process for the awards.
Your support allows researchers to explore the relationship between the processes of aging and age-related diseases and conditions such as Alzheimer’s disease, Cancer, Diabetes, Osteoporosis, and Parkinson’s disease.
Over our 35 years, AFAR is proud to have supported researchers whose work in Alzheimer's, dementia, and cognitive health continues to be cited and awarded:
Cited in The New York Times, The Wall Street Journal, and US News and World Reports Health Day, 2005 Beeson Scholar and 2000 COE Fellow, Malaz Boustani, MD, MPH, is a sought-after expert on health care delivery related to Alzheimer’s disease and memory.
Inna Slutsky, PhD’s 2008 New Investigator Award provided early funding for her research uncovering a molecular mechanism behind hyperactivity in the brains of Alzheimer’s patients. This year, Dr. Slutsky received a MetLife Foundation Promising Investigator Award for Medical Research in Alzheimer’s Disease.
1995 Beeson Scholar and 2006 MetLife Foundation Award Recipient, David M. Holtzman, MD,is chair of the Department of Neurology at Washington University in St. Louis and an international authority in the field of AD.
2003 Beeson Scholar, Reisa A. Sperling, MD, MMSc, is a neurologist specializing in dementia and imaging research who is featured frequently in major news outlets such as The New York Times for her work on developing screening tools and treatments for Alzheimer’s disease. She is at the forefront of national efforts toward earlier diagnosis of and treatment of AD.
By investigating Alzheimer’s disease in the context of aging-related processes,
AFAR is moving forward research to help us all live better longer.
